C. Derk

发表

C. Derk, 2006, Postgraduate medicine.

Inclusion body myositis in connective tissue disorders: case report and review of the literature

S. Mandel, F. Vivino, C. T. Derk, 2003, Clinical Rheumatology.

Statins and the vasculopathy of systemic sclerosis: potential therapeutic agents?

S. Jimenez, C. Derk, 2006, Autoimmunity reviews.

Stem Cells and Cloning: Advances and Applications Progress toward curing Hiv infection with hematopoietic cell transplantation

J. Burnett, J. Kurtzberg, E. Shpall, 2022 .

Systemic sclerosis: current views of its pathogenesis.

S. Jimenez, C. Derk, 2003, Autoimmunity reviews.

Tuberculous tonsillitis in a patient receiving etanercept treatment

R. Dehoratius, C. Derk, 2003, Annals of the rheumatic diseases.

Dialysis-associated systemic fibrosis (nephrogenic fibrosing dermopathy): study of inflammatory cells and transforming growth factor beta1 expression in affected skin.

S. Jimenez, K. Latinis, J. Shanahan, 2004, Arthritis and rheumatism.

The Gastrointestinal Manifestations of Systemic Lupus Erythematosus: A Survey of the Literature

C. Derk, S. Schulz, 2009 .

Mortality and survival in systemic sclerosis: a review of recent literature

C. Derk, D. Poudel, 2018, Current opinion in rheumatology.

Reporting items for capillaroscopy in clinical research on musculoskeletal diseases: a systematic review and international Delphi consensus.

P. Merkel, S. Blaise, J. Cracowski, 2020, Rheumatology.

A prospective open-label study of mycophenolate mofetil for the treatment of diffuse systemic sclerosis.

M. Naik, C. Derk, Wen Xiong, 2009, Rheumatology.

Advances in disease-specific treatment of systemic sclerosis

M. Naik, C. Derk, M. Shenin, 2009 .

Treatment of systemic sclerosis: potential role for stem cell transplantation

C. Derk, Wen Xiong, W. Xiong, 2009, Stem cells and cloning : advances and applications.

Determinants of mortality in systemic sclerosis: a focused review

Divya Jayakumar, S. Sehra, A. Danve, 2018, Rheumatology International.

Predictors of early mortality in systemic sclerosis: a case–control study comparing early versus late mortality in systemic sclerosis

S. Jimenez, C. Derk, G. Huaman, 2012, Rheumatology International.

Management of gastrointestinal manifestations in systemic sclerosis (scleroderma)

G. Noaiseh, C. Derk, Sophia Li, 2012 .

Following the Molecular Pathways toward an Understanding of the Pathogenesis of Systemic Sclerosis

S. Jimenez, C. Derk, 2004, Annals of Internal Medicine.

HLA and autoantibodies define scleroderma subtypes and risk in African and European Americans and suggest a role for molecular mimicry

Ami A. Shah, C. Rotimi, A. Adeyemo, 2019, Proceedings of the National Academy of Sciences.

Development of pulmonary hypertension in a high-risk population with systemic sclerosis in the Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma (PHAROS) cohort study.

M. Mayes, D. Furst, R. Simms, 2014, Seminars in arthritis and rheumatism.

Systemic Sclerosis: Current State and Survival After Lung Transplantation

C. Derk, L. Gabrielyan, A. Minalyan, 2021, Cureus.

Prevalence and factors associated with left ventricular dysfunction in the EULAR Scleroderma Trial and Research group (EUSTAR) database of patients with systemic sclerosis

D. Farge, M. Vonk, E. Hachulla, 2009, Annals of the rheumatic diseases.

Predictors of inpatient mortality in patients with systemic sclerosis: a case control study

J. Baker, S. Sehra, C. Derk, 2016, Clinical Rheumatology.

Predictors of a Cerebrovascular Accident in a Population of Systemic Sclerosis Patients Followed at a Large Academic Center with a Dedicated Scleroderma Center

C. Derk, C. Inserra, 2020, Open Journal of Rheumatology and Autoimmune Diseases.

Vasodilatory Therapeutics in the Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma (PHAROS) Cohort

B. Segal, J. Gordon, M. Murtaugh, 2012 .

Eosinophilic fasciitis: demographics, disease pattern and response to treatment: report of 12 cases and review of the literature

C. Derk, L. Bischoff, 2007, International journal of dermatology.

Eosinophilic Fasciitis in a Pediatric Patient

K. Loupasakis, C. Derk, 2010, Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases.

Baseline characteristics and follow-up in patients with normal haemodynamics versus borderline mean pulmonary arterial pressure in systemic sclerosis: results from the PHAROS registry

M. Mayes, D. Furst, R. Domsic, 2012, Annals of the rheumatic diseases.

Increased incidence of carcinoma of the tongue in patients with systemic sclerosis.

S. Jimenez, J. Spiegel, C. Derk, 2005, The Journal of rheumatology.

Systemic Sclerosis Mortality in the United States: 1999–2002 Implications for Patient Care

F. Mendoza, C. Derk, 2007, Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases.

Morbidity and mortality of patients diagnosed with systemic sclerosis after the age of 75: a nested case-control study

S. Jimenez, C. Artlett, C. Derk, 2006, Clinical Rheumatology.

Disease-modifying drugs for systemic sclerosis: why have we not found them yet?

C. Derk, 2011, Expert review of clinical immunology.

Adipose‐Derived Regenerative Cell Transplantation for the Treatment of Hand Dysfunction in Systemic Sclerosis: A Randomized Clinical Trial

Richard W. Martin, M. Mayes, D. Furst, 2022, Arthritis & Rheumatology (Hoboken, N.j.).

Survival and Predictors of Mortality in Systemic Sclerosis‐Associated Pulmonary Arterial Hypertension: Outcomes From the Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma Registry

D. Furst, R. Simms, J. Gordon, 2014, Arthritis care & research.

Endothelin receptor antagonists as disease modifiers in systemic sclerosis.

C. Derk, N. Shetty, 2011, Inflammation & allergy drug targets.

Septic arthritis caused by Actinobacillus ureae in a patient with rheumatoid arthritis receiving anti-tumor necrosis factor-alpha therapy.

R. DeHoratius, P. Kaur, C. Derk, 2004, The Journal of rheumatology.

Acute myocardial infarction in systemic sclerosis patients: a case series

S. Jimenez, C. Derk, 2007, Clinical Rheumatology.

Scleroderma lung disease: treatment with cyclophosphamide

D. Michel, C. Derk, S. Schulz, 2006, Expert review of clinical immunology.

Diagnosis and Management of Systemic Sclerosis

C. Derk, 2012 .

A prospective, open-label, non-comparative study of ambrisentan with anti-fibrotic agent combination therapy in the treatment of diffuse systemic sclerosis

R. Neubauer, C. Derk, A. Schorpion, 2018, BMC Rheumatology.

Anti-RNA Polymerase III Antibodies in Systemic Sclerosis

C. Derk, A. Kelly, 2015 .

Gastric Antral Vascular Ectasia in Systemic Sclerosis: Demographics and Disease Predictors

V. Steen, C. Derk, M. O'Brien, 2010, The Journal of Rheumatology.

Prevalence, Correlates and Outcomes of Gastric Antral Vascular Ectasia in Systemic Sclerosis: A EUSTAR Case-control Study

D. Khanna, V. Steen, F. Ingegnoli, 2014, The Journal of Rheumatology.

Systemic sclerosis without antinuclear antibodies or Raynaud's phenomenon: a multicentre study in the prospective EULAR Scleroderma Trials and Research (EUSTAR) database.

A. Tyndall, P. Carreira, U. Walker, 2013, Rheumatology.

A primary care approach to Sjögren's syndrome

F. Vivino, C. Derk, 2004, Postgraduate medicine.

Unmet Patient Needs in Systemic Sclerosis

C. Derk, Tamara T Rubenzik, 2009, Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases.

Phosphodiesterase-5 inhibitors for the treatment of Raynaud's: a novel indication

C. Derk, A. D. De LaVega, 2009 .

Mortality, Recurrence, and Hospital Course of Patients with Systemic Sclerosis-related Acute Intestinal Pseudo-obstruction

N. Sandorfi, C. Derk, C. Mecoli, 2014, The Journal of Rheumatology.

Avascular necrosis in systemic sclerosis patients: a case-based review of demographics, presentation, and management

C. Derk, Bikash Basyal, Binita Bhandari, 2020, Clinical Rheumatology.

Phosphodiesterase-5 inhibitors for the treatment of Raynaud's: a novel indication.

C. Derk, A. D. De LaVega, 2009, Expert opinion on investigational drugs.

Clinical and serological features of systemic sclerosis in a multicenter African American cohort

Ami A. Shah, M. Mayes, E. Remmers, 2017, Medicine.

Brief Report: Whole‐Exome Sequencing to Identify Rare Variants and Gene Networks That Increase Susceptibility to Scleroderma in African Americans

Ami A. Shah, C. Rotimi, A. Adeyemo, 2018, Arthritis & rheumatology.

Risk Factors for Mortality and Cardiopulmonary Hospitalization in Systemic Sclerosis Patients At Risk for Pulmonary Hypertension, in the PHAROS Registry

M. Mayes, D. Furst, R. Simms, 2018, The Journal of Rheumatology.

Sjogren’s syndrome: models of pathogenesis and treatment targets

C. Derk, 2005 .

Goodpasture-like syndrome induced by D-penicillamine in a patient with systemic sclerosis: report and review of the literature.

S. Jimenez, C. Derk, 2003, The Journal of rheumatology.

Initial presentation of acute transverse myelitis in systemic lupus erythematosus: demographics, diagnosis, management and comparison to idiopathic cases

C. Derk, A. Mehta, A. Kebede, 2012, Rheumatology International.

A cohort study of cancer incidence in systemic sclerosis.

S. Jimenez, C. Artlett, C. Derk, 2006, The Journal of rheumatology.

A case of anti-Jo1 myositis with pleural effusions and pericardial tamponade developing after exposure to a fermented Kombucha beverage

M. Curtis, N. Sandorfi, C. Derk, 2004, Clinical Rheumatology.

Primary B-cell lymphoma of the tongue in a patient with systemic sclerosis.

S. Jimenez, C. Derk, Raymond Conway, 2004, Oral oncology.

Connective tissue disease related interstitial lung diseases and idiopathic pulmonary fibrosis: provisional core sets of domains and instruments for use in clinical trials

Ami A. Shah, R. Hubbard, W. Dixon, 2013, Thorax.

Mortality, length of stay and cost of hospitalization among patients with systemic sclerosis: results from the National Inpatient Sample

M. George, N. Sandorfi, C. Derk, 2018, Rheumatology.

Utility of B-type natriuretic peptides in the assessment of patients with systemic sclerosis-associated pulmonary hypertension in the PHAROS registry.

D. Furst, R. Simms, J. Gordon, 2017, Clinical and experimental rheumatology.

Associations of breast cancer development in patients with systemic sclerosis: an exploratory study

C. Derk, 2007, Clinical Rheumatology.

Systemic lupus erythematosus and acute pancreatitis: a case series

R. DeHoratius, C. Derk, 2004, Clinical Rheumatology.

Anti-ribosomal-P antibodies in lupus nephritis, neuropsychiatric lupus, lupus hepatitis, and Chagas’ disease: promising yet limited in clinical utility

M. Abraham, C. Derk, 2014, Rheumatology International.

Gastric Antral Vascular Ectasia in Systemic Sclerosis

C. Derk, Jill Johnson, 2011, International journal of rheumatology.

A Scleroderma Patient with Acute Drop in Hemoglobin and Occult Blood in Stool

C. Derk, Jayne Littlejohn, 2011 .

Diffuse Cutaneous Mucinosis in Dermatomyositis: A Case Report and Review of the Literature

C. Derk, A. Perel-Winkler, 2014, Case Reports in Dermatological Medicine.

Pantoprazole and perinuclear antineutrophil cytoplasmic antibody-associated vasculitis.

N. Sandorfi, C. Derk, D. Jacobs-Kosmin, 2006, The Journal of rheumatology.

Autoantibodies in patients with systemic sclerosis and cancer: a case-control study.

S. Jimenez, C. Artlett, C. Derk, 2003, The Journal of rheumatology.

Outcomes of Barrett's oesophagus related to systemic sclerosis: a 3-year EULAR Scleroderma Trials and Research prospective follow-up study.

L. Mouthon, E. Hachulla, M. Matucci-Cerinic, 2011, Rheumatology.

Disease modification in systemic sclerosis: the search for the Holy Grail

S. Sehra, C. Derk, 2013 .

A retrospective randomly selected cohort study of D‐penicillamine treatment in rapidly progressive diffuse cutaneous systemic sclerosis of recent onset

S. Jimenez, C. Derk, G. Huaman, 2008, The British journal of dermatology.

Treatment of systemic sclerosis: potential role for stem cell transplantation

C. Derk, W. Xiong, 2009, Stem cells and cloning : advances and applications.

Treatment of systemic sclerosis: potential role for stem cell transplantation.

C. Derk, Wen Xiong, 2009, Stem cells and cloning : advances and applications.

Benefit of anti-TNF a treatment for nephrotic syndrome in a patient with juvenile inflammatory bowel disease associated spondyloarthropathy complicated with amyloidosis and glomerulonephritis

E. Lerut, F. Hiepe, G. Littlejohn, 2003 .

Adipose-Derived Regenerative Cell Transplantation in Systemic Sclerosis: Scleroderma Treatment with Celution Processed Adipose Derived Regenerative Cells- a Randomized Clinical Trial.

Richard W. Martin, M. Mayes, D. Furst, 2022, Arthritis & rheumatology.

Preliminary criteria for the very early diagnosis of systemic sclerosis: results of a Delphi Consensus Study from EULAR Scleroderma Trials and Research Group

M. L. Lopes, A. Gabrielli, U. Müller-Ladner, 2010, Annals of the rheumatic diseases.

Connective tissue disease related interstitial lung diseases and idiopathic pulmonary fibrosis: provisional core sets of domains and instruments for use in clinical trials

Ami A. Shah, R. Hubbard, W. Dixon, 2013, Thorax.

Prevalence, Correlates and Outcomes of Gastric Antral Vascular Ectasia in Systemic Sclerosis: A EUSTAR Case-control Study

D. Khanna, V. Steen, F. Ingegnoli, 2014, The Journal of Rheumatology.

Ulcers of the Ventral Aspect of Fingers.

M. Rosenbach, S. Grewal, C. Derk, 2016, JAMA dermatology.

Pericardial effusions and cardiac tamponade in hospitalized systemic sclerosis patients: analysis of the national inpatient sample

C. Derk, Bikash Basyal, Waqas Ullah, 2023, BMC Rheumatology.

Clinically Symptomatic Pericardial Effusions in Hospitalized Systemic Sclerosis Patients: Demographics and Management

H. Hosoya, C. Derk, 2018, BioMed research international.

Rheumatoid arthritis: an update.

C. Derk, 2005, Delaware medical journal.

group data base Scleroderma Trials And Research (EUSTAR) in systemic sclerosis - a report from the EULAR Clinical risk assessment of organ manifestations

Gianluigi, Wigley, A. Gabrielli, 2007 .

Comment on: A prospective open-label study of mycophenolate mofetil for the treatment of diffuse systemic sclerosis: reply

M. Naik, C. Derk, S. Schulz, 2010 .

Unmet Patient Needs in Systemic Sclerosis

C. Derk, Tamara T Rubenzik, 2009, Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases.